Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Huandi Qiu"'
Autor:
Lingyun Zhou, Linye He, Chang-Hai Liu, Huandi Qiu, Li Zheng, Klarke Michael Sample, Qin Wu, Jiaxin Li, Kunlin Xie, Javier Ampuero, Zhihui Li, Duoduo Lv, Miao Liu, Manuel Romero-Gómez, Yiguo Hu, Hong Tang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-25 (2023)
Abstract Background Liver cancer stem cells (LCSCs) play an important role in hepatocellular carcinoma (HCC), but the mechanisms that link LCSCs to HCC metastasis remain largely unknown. This study aims to reveal the contributions of NRCAM to LCSC fu
Externí odkaz:
https://doaj.org/article/3ee30e25a973421c9596444d1bbe194d
Autor:
Qiang Qiu, Yuanyuan Sun, Linyu Yang, Qingqing Li, Yunyu Feng, Mengyuan Li, Yuexia Yin, Li Zheng, Ning Li, Huandi Qiu, Xue Cui, Wei He, Bochuan Wang, Cong Pan, Zi Wang, Juan Huang, Klarke M. Sample, Zhihui Li, Yiguo Hu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-14 (2023)
Abstract We report herein that TSPAN32 is a key node factor for Philadelphia (Ph+) leukemia pathogenesis. We found that TSPAN32 expression was repressed by BCR-ABL and ectopic TSPAN32 expression upon Imatinib treatment inhibited the proliferation of
Externí odkaz:
https://doaj.org/article/21964beafc5b4db68d3f5622b80d2d22
Autor:
Qiang Qiu, Linyu yang, Yunyu Feng, Zejiang Zhu, Ning Li, Li Zheng, Yuanyuan Sun, Cong Pan, Huandi Qiu, Xue Cui, Wei He, Fang Wang, Yuyao Yi, Minghai Tang, Zhuang Yang, Yunfan Yang, Zhihui Li, Lijuan Chen, Yiguo Hu
Publikováno v:
Bioactive Materials, Vol 21, Iss , Pp 483-498 (2023)
Purinostat Mesylate (PM) is a novel highly selective and active HDAC I/IIb inhibitor, and the injectable formulation of PM (PMF) based on the compound prescription containing cyclodextrin completely can overcome PM's poor solubility and improves its
Externí odkaz:
https://doaj.org/article/0d7da28d05d149efa099f6bd699967a1
Publikováno v:
Frontiers in Chemistry, Vol 11 (2023)
Lanthanide coordinating polymeric microparticles have witnessed increasing research interests during the past decades due to their versatile morphology and tunable fluorescent properties. Herein, we have synthesized an amidoximed block copolymer cont
Externí odkaz:
https://doaj.org/article/76fd0696a1e94323935bf9be57527d95
Autor:
Li Zheng, Cong Pan, Wanli Tian, Cailing Liang, Yunyu Feng, Wei He, Zirong Yang, Bochuan Wang, Qiang Qiu, Ning Li, Yuanyuan Sun, Huandi Qiu, Klarke M. Sample, Lingyun Zhou, Xianjun Zhu, Yiguo Hu
Publikováno v:
Cellular Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be74f1c2844c96936e56a38172c6c2ab
https://doi.org/10.1007/s13402-023-00797-7
https://doi.org/10.1007/s13402-023-00797-7
Autor:
Ning, Li, Nan, Wang, Wei, He, Yunyu, Feng, Qiang, Qiu, Huandi, Qiu, Li, Zheng, Yuexia, Yin, Bochuan, Wang, Yuanyuan, Sun, Cong, Pan, Klarke M, Sample, Juan, Huang, Zhiguang, Su, Zhihui, Li, Haojian, Zhang, Yiguo, Hu
Publikováno v:
International Journal of Biological Sciences. 18:2277-2291
RORA plays an important role in regulating circadian rhythms, inflammation, metabolism and cellular development. Herein, we explore the roles of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c08fad5cab9789b10543b8c145dd0f4e
https://doi.org/10.7150/ijbs.68939
https://doi.org/10.7150/ijbs.68939
Autor:
Qiang Qiu, Linyu yang, Yunyu Feng, Zejiang Zhu, Ning Li, Li Zheng, Yuanyuan Sun, Cong Pan, Huandi Qiu, Xue Cui, Wei He, Fang Wang, Yuyao Yi, Minghai Tang, Zhuang Yang, Yunfan Yang, Zhihui Li, Lijuan Chen, Yiguo Hu
Publikováno v:
Bioactive materials. 21
Purinostat Mesylate (PM) is a novel highly selective and active HDAC I/IIb inhibitor, and the injectable formulation of PM (PMF) based on the compound prescription containing cyclodextrin completely can overcome PM's poor solubility and improves its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a36eeb44e1c54e03160aa6d0ef3d1b3
https://pubmed.ncbi.nlm.nih.gov/36185739
https://pubmed.ncbi.nlm.nih.gov/36185739
Autor:
Lijuan Chen, Linyu Yang, Shengyong Yang, Mengyuan Li, Yiguo Hu, Cailing Liang, Yuyao Yi, Li Zheng, Huandi Qiu, Cong Pan, Qiang Qiu, Ning Li, Fang Wang, Dongni Yi, Minghai Tang
Publikováno v:
Oncotarget
Multiple myeloma (MM) pathogenesis remains incompletely understood and biomarkers predicting treatment response still remain lacking. Here we describe the rational mechanisms of combining targeting glautaminase1 (GLS1) with other chemo-reagents for M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077fc4d026beb420fe4c6df2f542243c
https://doi.org/10.18632/oncotarget.27243
https://doi.org/10.18632/oncotarget.27243